Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis

Journal of Rheumatology

Volumn 38, Issue 12, 2011, Pages 2536-2539

  Ruiz Esquide, Virginia ^a   Gómez Puerta, José A ^a   Cañete, Juan D ^a   Graell, Eduard ^b   Vazquez, Ivonne ^b   Ercilla, M Guadalupe ^a   Viñas, Odette ^a   Gómez Centeno, Antonio ^b   Haro, Isabel ^c   Sanmartí, Raimon ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

^c INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

Author keywords

Prognosis; Radiographic damage; Rheumatoid arthritis; Smoking

Indexed keywords

AUROTHIOMALATE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GOLD; HLA DR ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOOT RADIOGRAPHY; GENOTYPE; HAND RADIOGRAPHY; HUMAN; JOINT INJURY; LARSEN SCORE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 82755176116     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110410     Document Type: Article

References (15)

1. Heliovaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5. (Pubitemid 24031583)
2. Saevarsdottir S, Wedren S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. Arthritis Rheum 2011;63:26-36.
3. Westhoff G, Rau R, Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology 2008;47:849-54. (Pubitemid 351796371)
4. Soderlin M, Petersson I, Bergman S, Svensson B. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: Experiences from BARFOT, a long-term observational study on early RA. Scand J Rheumatol 2011;40:249-55.
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
6. Sanmarti R, Graell E, Perez ML, Ercilla G, Vinas O, Gomez-Puerta JA, et al. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis. Arthritis Res Ther 2009;11:R135.
7. Kirwan JR. Using the Larsen index to assess radiographic progression in rheumatoid arthritis. J Rheumatol 2000;27:264-8. (Pubitemid 30058663)
8. Sanmarti R, Gomez A, Ercilla G, Gratacos J, Larrosa M, Suris X, et al. Radiological progression in early rheumatoid arthritis after DMARDS: A one-year follow-up study in a clinical setting. Rheumatology 2003;42:1044-9. (Pubitemid 37220991)
9. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004;50:3085-92. (Pubitemid 39371983)
10. Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieude P, et al. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 2008;67:466-70. (Pubitemid 351498425)
11. Finckh A, Dehler S, Costenbader KH, Gabay C. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2007;66:1066-71. (Pubitemid 47122321)
12. Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 2005;23:861-6. (Pubitemid 43040515)
13. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: Role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004;63:1090-5. (Pubitemid 39120360)
14. Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M, et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology 2006;45:734-40. (Pubitemid 43985343)
15. Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D, et al. Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 2008;67:1529-34.